Walter Porter
Family · Chattanooga, TNNPI 1083191191
Payments from drug & device makers
Across 186 payments — averaging $18.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$553
- Novo Nordisk$422
- Pfizer$241
- Incyte Corporation$219
- Lilly USA, LLC$203
- Biohaven Pharmaceutical Holding Company Ltd.$169
- plus $2K from 31 others
What the payments were for
- Food & beverage$3,23794%
- Education$2206%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 37 | $553 |
| Novo Nordisk | 29 | $422 |
| Pfizer | 14 | $241 |
| Incyte Corporation | 5 | $219 |
| Lilly USA, LLC | 13 | $203 |
| Biohaven Pharmaceutical Holding Company Ltd. | 13 | $169 |
| Sanofi-aventis U.S. LLC | 8 | $141 |
| Amgen(2 entities) | 9 | $128 |
| Johnson & Johnson | 1 | $127 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $125 |
| Gilead | 1 | $107 |
| Eisai Inc. | 5 | $97 |
| Daiichi Sankyo Inc. | 2 | $90 |
| Astellas Pharma US Inc | 4 | $87 |
| Stemline Therapeutics Inc. | 1 | $67 |
| AVEO Pharmaceuticals, Inc. | 2 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $63 |
| AstraZeneca | 4 | $58 |
| Abbott | 3 | $57 |
| Merck | 3 | $53 |
| Idorsia Pharmaceuticals US Inc | 3 | $42 |
| Bayer | 2 | $36 |
| Regeneron Healthcare Solutions, Inc. | 1 | $33 |
| Esperion Therapeutics, Inc. | 2 | $27 |
| Nevro Corp. | 1 | $27 |
| Bristol Myers Squibb | 1 | $26 |
| Tersera Therapeutics LLC | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| GSK | 1 | $20 |
| Boehringer Ingelheim | 1 | $19 |
| Sanofi | 1 | $17 |
| Genmab U.S., Inc. | 1 | $17 |
| Genentech USA, Inc. | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $16 |
| Exact Sciences | 1 | $15 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RYBREVANT$127
How this compares
$3,457 in reported general payments places this provider in the 85th percentile of 6,706 family providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IbrancePalbociclib | 13 | $182,281 |
| EliquisApixaban | 13 | $12,115 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $8,028 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 34 | $857 |
| Atorvastatin Calcium | 41 | $714 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 38 | $518 |
| Gabapentin | 26 | $394 |
| Rosuvastatin Calcium | 27 | $350 |
| Letrozole | 14 | $315 |
| Famotidine | 12 | $310 |
| Levothyroxine Sodium | 36 | $255 |
| Losartan Potassium | 15 | $245 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 13 | $232 |
| Tamsulosin Hcl | 17 | $227 |
| Ondansetron OdtOndansetron | 11 | $219 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerIbrance, Eliquis | $241 | $194,39626 claims |
| GSKTrelegy Ellipta | $20 | $8,02811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,706 family providers in Tennessee.
Other family in Chattanooga
- Jennifer SparksChattanooga$120K
- Marcie BeasleyChattanooga$91K
- Amy RainsChattanooga$55K
- Bronte NaplesChattanooga$26K
- Ernest BrandtChattanooga$21K
- Stacy BrownMt Juliet$719K
- Dana WebberKnoxville$499K
- Brandy BiedermanHixson$448K
- Cynthia MillerMurfreesboro$384K
- Tamera ThoenerNashville$254K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.